T2 Biosystems, Inc. announced that its Board of Directors has appointed Aparna Ahuja, MD, as Chief Medical Officer (CMO), effective immediately. In her new role, Dr. Ahuja will act as the company’s key medical spokesperson providing leadership and strategic direction for all medical, clinical and scientific affairs activities for T2 Biosystems. Dr. Ahuja possesses extensive global experience in Laboratory Medicine and in the medical device and diagnostics industry. Most recently, she served as Worldwide Vice President, Medical Affairs at Becton Dickinson.